A Topical Prostaglandin for Glaucoma
Lantaoprost, a prostaglandin F2-alpha analog, has been approved by the FDA for topical treatment of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension refractory to other drugs....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: A Topical Prostaglandin for Glaucoma
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 987
Article Code: 987b
Date: November 8, 1996
Volume: 38
Pages: 100-101
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 987
Article Code: 987b
Date: November 8, 1996
Volume: 38
Pages: 100-101
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)